NOVO NORDISK A/S
Patent Owner
Stats
- 605 US PATENTS IN FORCE
- 76 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 605 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 68,661 Total Citation Count
- May 07, 1981 Earliest Filing
- 1,164 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0000,742 Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol CoatingJan 29, 15Jan 04, 18[A61K]
2017/0361,029 AN INJECTION NEEDLE ASSEMBLY FOR AN INJECTION DEVICE AND AN INJECTION DEVICE COMPRISING SUCH ASSEMBLYJan 22, 16Dec 21, 17[A61M]
2017/0348,491 HANDHELD SPRING DRIVEN INJECTION DEVICE WITH FORCE REGULATIONJan 06, 16Dec 07, 17[A61M]
2017/0340,808 Kit Comprising a Medical Accessory Device and a Dummy UnitJan 14, 16Nov 30, 17[G09B, A61M]
2017/0338,864 A Wireless Data Communication Module for Drug Injection DevicesJan 08, 16Nov 23, 17[H04B, H01Q, A61M]
2017/0326,302 Drug Injection Device with Visual End-Of-Contents Indicator SystemJan 08, 16Nov 16, 17[A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9896513 Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitorMar 14, 14Feb 20, 18[A61K, C12P, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0334,971 Alpha-1-Antitrypsin (A1AT) Fusion Proteins and Uses ThereofAbandonedDec 22, 15Nov 23, 17[A61K, C07K]
2017/0020,992 Factor VIII Molecules with Reduced VWF BindingAbandonedOct 07, 16Jan 26, 17[A61K, C07K]
2017/0007,712 GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODSAbandonedAug 01, 16Jan 12, 17[A61K, C12N, C07K]
2017/0008,928 NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOFAbandonedJul 06, 16Jan 12, 17[A61K, C07K]
2016/0297,892 Novel Methods and Antibodies for Treating CoagulapathyAbandonedNov 07, 14Oct 13, 16[C07K]
2016/0207,977 Compounds Suitable for Treatment of HaemophiliaAbandonedJun 10, 14Jul 21, 16[A61K, C07K]
2016/0200,795 FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIIIAbandonedDec 18, 15Jul 14, 16[A61K, C07K]
2016/0193,154 Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and an Anionic Copolymer CoatingAbandonedJul 11, 14Jul 07, 16[A61K]
2016/0193,353 FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIIIAbandonedMar 16, 16Jul 07, 16[A61K]
2016/0136,246 Novel Uses of GLP-1 Receptor Agonists in Patients Treated with Insulin and/or Suffering from Type 1 DiabetesAbandonedJun 23, 14May 19, 16[A61K]
2016/0106,814 Novel Oral Pharmaceutical Composition for Treatment of DiabetesAbandonedMay 30, 14Apr 21, 16[A61K]
2015/0376,262 Factor VIII Molecules With Reduced VWF BindingAbandonedSep 11, 15Dec 31, 15[A61K, C07K]
2015/0344,540 NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITYAbandonedDec 19, 13Dec 03, 15[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.